SCHEMBL95032

SCHEMBL95032

[CH2]c1ccc(NS(=O)(=O)c2cccc(Cl)c2C)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 4/20 0.59
EDNRA P25101 3/20 0.53
EDNRB P24530 2/20 0.53
SLC40A1 Q9NP59 1/20 0.50
PGR P06401 2/20 0.48
CCR4 P51679 1/20 0.47
ALDH1A1 P00352 2/20 0.45
ATM Q13315 1/20 0.44
GSPT1 P15170 1/20 0.44
DDB1 Q16531 1/20 0.44
CRBN Q96SW2 1/20 0.44
IDH2 P48735 1/20 0.43
WDR5 P61964 1/20 0.43
PKM P14618 1/20 0.43
HDAC3 O15379 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC10 Q969S8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7578851 0.88 HSD11B1 (0.58) HSD11B1EDNRAEDNRBSLC40A1PGR
SCHEMBL3768958 0.86 HSD11B1 (0.60) HSD11B1EDNRAEDNRBSLC40A1PGR
SCHEMBL7572722 0.85 ALDH1A1 (0.56) HSD11B1EDNRAEDNRBSLC40A1PGR
SCHEMBL95664 0.84 PGR (0.65) SLC40A1PGRCCR4ALDH1A1
SCHEMBL96292 0.84 PGR (0.65) PGRALDH1A1PKMHDAC3HDAC4
SCHEMBL7577401 0.81 HSD11B1 (0.61) HSD11B1EDNRAEDNRBSLC40A1
SCHEMBL132296 0.79 ATM (0.62) SLC40A1PGRCCR4ALDH1A1ATM
SCHEMBL7591248 0.79 HSD11B1 (0.63) HSD11B1EDNRAEDNRBSLC40A1CCR4
SCHEMBL96179 0.79 ATM (0.55) SLC40A1PGRALDH1A1ATMIDH2
SCHEMBL95378 0.78 ALDH1A1 (0.56) EDNRAEDNRBSLC40A1ALDH1A1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362252-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-01-29 US disclosed
EP-1797082-B1 CARBOSTYRIL COMPOUND OTSUKA PHARMA CO LTD (JP) 2012-08-29 EP disclosed
EP-2426128-A1 Carbostyril compound Otsuka Pharmaceutical Co., Limited (JP) 2012-03-07 EP disclosed
US-20100261705-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. 2010-10-14 US disclosed
US-7777038-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-08-17 US disclosed
US-20090326008-A1 NF-kappa B Inhibitor OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2009-12-31 US disclosed
CN-101489555-A Nf-kappa OTSUKA PHARMA CO LTD (JP) 2009-07-22 CN disclosed
EP-2043644-A1 NF- B INHIBITOR Otsuka Pharmaceutical Co., Ltd. (JP) 2009-04-08 EP disclosed
WO-2008010601-A1 NF- ϰB INHIBITOR OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2008-01-24 WO disclosed
US-20070179173-A1 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090326008-A1 NF-kappa B Inhibitor NFKBIA, NFKB2, IKBKB HSD11B1 170/4885EDNRA 1081/4885EDNRB 208/4885
US-20070179173-A1 Carbostyril compound GTF2F1, F3, GTF2F2 HSD11B1 455/4885EDNRA 2193/4885EDNRB 2429/4885
US-20100261705-A1 CARBOSTYRIL COMPOUND GTF2F1, F3, GTF2F2 HSD11B1 455/4885EDNRA 2193/4885EDNRB 2429/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.